Aqualiv Tech. - Long-invest der besondren Art!
Seite 126 von 130 Neuester Beitrag: 17.03.13 12:36 | ||||
Eröffnet am: | 12.01.12 18:19 | von: dannyo | Anzahl Beiträge: | 4.228 |
Neuester Beitrag: | 17.03.13 12:36 | von: Watergames | Leser gesamt: | 238.104 |
Forum: | Hot-Stocks | Leser heute: | 79 | |
Bewertet mit: | ||||
Seite: < 1 | ... | 124 | 125 | | 127 | 128 | ... 130 > |
Auf Dich werden bald noch mehr Augen gerichtet sein... "großes Grinsen"
Keep cool.
Gestern war ein schöner Tag für Aqualiv. Der Kurs ist schön gestiegen auf fast 28% in den USA. Hoffe deshalb das diese Tendenz weiter so anhält bis die News erscheinen.
Weniger schön war gestern das Verhalten einiger Foumsteilnehmer, nur weil der Kurs zwischenzeitlich auf 42% steigt muss man nicht gleich durchdrehen.
Bleibt cool und professionell
Wünsche euch einen schönen Nachmittag, um 15:30 geht es in den USA los.
ein bisschen kognitive Dissonanz? Im ureigenen Interesse würde Aqualiv sofort bzw. unverzüglich eine Pressemeldung abgegeben wenn es mit den 50 Mil. geklappt hätte. Alles andere wäre ja geschäftsschädigend bzw. der CEO wäre in diesem Falle sofort abzulösen.
my2cent
Sollten in absehbarer Zeit aber doch die ersehnten positive News kommen, dann kann man schon mal den Karibikurlaub planen.
Verzögerungen bein solchen Deals sind normal. Also, noch ist nicht aller Tage Abend.
Mir wär natürlich auch lieber sie würde schon auf einem USD hoch sein-
aber Rom wurde ja auch nicht an einem Tag aufgebaut.
Also Leute-klotzen statt motzen,wäre hier angebrachter.
fg
AquaLiv Technologies, Inc. and Its Subsidiary, AquaLiv, Inc., Release Funding Updates
AquaLiv Technologies Receives $3.5 Million Funding Commitment
SEATTLE, May 4, 2012 /PRNewswire via COMTEX/ -- AquaLiv Technologies, Inc. AQLV -19.15% and its subsidiary, AquaLiv, Inc., have released an update concerning the previously announced $50 million capital infusion for AquaLiv, Inc. The company is also pleased to announce that it has executed a separate $3.5 million financing agreement.
In January, the company announced that its subsidiary, AquaLiv, Inc., expected the first tranche of funds from a $50 million funding round to arrive in April. Today the company released an update about the investment.
"The funder estimated that the first tranche of funds should be issued in April, but it is going to take longer," stated AquaLiv CEO, Craig Hoffman. "The Conditional Commitment Letter issued by the funder does not expire until June 15, so apparently they did anticipate this could take additional time to put together."
According to the company, the funding deal is progressing even though definitive contracts have not yet been issued. The funder requested an additional large package of underwriting documents on April 2nd and AquaLiv delivered the requested documents on April 13th. At this time, no further documentation has been requested.
"We hope to have more updates on this funding soon," added Mr. Hoffman. "However, in light of the economic environment and the difficulty in raising capital, we have continued with additional fundraising efforts during this period. This is not an indication of our confidence in the funding group, but a prudent business hedge for our future."
As part of that effort, the company recognized the need for its own funding separate from AquaLiv, Inc. In order to strengthen its operations and capital structure, the company executed a $3.5 million financing agreement. The company views the terms on the funding as significantly better than the cost of funds to the company previously.
The first funds to arrive, whether from the $50 million group or from another party, will be used to acquire Dr. Takemi Ichimura's (AquaLiv's Chief Science Officer) Japanese operations. The acquisition includes an established corporate entity with inventory and existing sales. The entity will be renamed AquaLiv Japan Co, Ltd. and its scope will encompass scientific research in addition to increased sales efforts throughout Asia.
"It is important that we both reduce our cost of funds and increase the share price to a point where institutional investors can consider AquaLiv," stated Bill Wright, CEO of AquaLiv Technologies, Inc. "The combination of strengthening our balance sheet, execution of funding, and sales increases through organic growth and the acquisition of Dr. Ichimura's operations should position us to attract larger shareholders interested in long term growth and results."
The company released its first agricultural product, AgSmart(TM) Rice, earlier this year, and is close to releasing their potato solution. AgSmart(TM) products increase crop yields without chemicals or genetic engineering and are organic standards compliant.
For more information about AquaLiv, visit their website: http://www.aqualiv.com
For more information about AquaLiv Technologies, Inc., visit their website: http://www.aqualivtech.com
About AquaLiv Technologies, Inc.:
AquaLiv Technologies, Inc., through its subsidiary, AquaLiv, Inc., offers unique solutions and for a variety of industries.
AquaLiv, Inc. is a life sciences research and development company creating novel products for numerous industries. The company's patented technology influences biological processes naturally and without chemical interaction. From increased crop yields to drug-free medicine, AquaLiv is providing innovative physics-based solutions to the world's largest problems. To learn more about AquaLiv, please visit: www.aqualiv.com .
Safe Harbor: Statements contained in this news release, other than those identifying historical facts, constitute "forward-looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934 and the Safe Harbor provisions as contained in the Private Securities Litigation Reform Act of 1995. Such forward-looking statements relating to the Company's future expectations, including but not limited to revenues and earnings, technology efficacy, strategies and plans, are subject to safe harbors protection. Actual Company results and performance may be materially different from any future results, performance, strategies, plans, or achievements that may be expressed or implied by any such forward-looking statements. The Company disclaims any obligation to update or revise any forward-looking statements.
http://www.marketwatch.com/story/...elease-funding-updates-2012-05-04
alles ok ist mit den Verträgen dann würde es mit der Finanzierung laufen.
Ist jemand anderer Meinung?
Gruß an Rudini, der wie immer unrecht hatte.
danke und schönes WE
Euer Sharedeals.com